AdvisorShares Vice ETF (VICE)
- Previous Close
31.05 - Open
31.25 - Bid --
- Ask 46.93 x 1200
- Day's Range
31.28 - 31.28 - 52 Week Range
23.90 - 31.28 - Volume
424 - Avg. Volume
453 - Net Assets 7.57M
- NAV 31.23
- PE Ratio (TTM) 20.49
- Yield 1.48%
- YTD Daily Total Return 15.57%
- Beta (5Y Monthly) 1.07
- Expense Ratio (net) 0.99%
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of (i) companies that derive at least 50% of their net revenue from tobacco and alcoholic beverages, (ii) companies that derive at least 50% of their net revenue from the food and beverage industry, and (iii) companies that derive at least 50% of their net revenue from gaming activities. It invests primarily in U.S. exchange listed equity securities, including common and preferred stock and ADRs.
AdvisorShares
Fund Family
Miscellaneous Sector
Fund Category
7.57M
Net Assets
2017-12-11
Inception Date
Performance Overview: VICE
View MoreTrailing returns as of 9/23/2024. Category is Miscellaneous Sector.
People Also Watch
Holdings: VICE
View MoreTop 10 Holdings (53.03% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: VICE
View MoreWith Its Attractive Footprint, Green Thumb Should Benefit From Growing US Legal Market Demand
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice TargetCuraleaf Offers Unique Investment Exposure to Both International Medical and American Cannabis
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
RatingPrice TargetGreen Thumb's Growth Should Benefit From Easing Federal Prohibition and New State Legalizations
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice TargetFirst Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
RatingPrice Target